MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2025 International Congress

    The Cultural Validation of the Montreal Cognitive Assessment in Bangladeshi Adults with Parkinson’s Disease in East London

    K. Dey, A. Shahid, M. Singh, A. Zirra, E. Camboe, R. Weil, D. Gallagher, C. Budu, T. Haque, S. Waters, S. Ali, N. Mukadam, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: This study investigated the cultural validity of the Montreal Cognitive Assessment (MoCA) in Bangladeshi adults with Parkinson’s disease in East London using the validated…
  • 2024 International Congress

    The Prevalence of Parkinson’s Disease with Dementia in a door to door survey done in a rural district in Hai, Kilimanjaro.

    E. Assey, R. Morton, J. Josephat, R. Valecha (Kilimanjaro, United Republic of Tanzania)

    Objective: To determine the prevalence of dementia in persons living with Parkinson's disease in a door to door survey. Background: Research suggests that up to…
  • 2024 International Congress

    Cognitive profile of Parkinson’s disease (PD) in the Framingham Heart Study (FHS)

    A. Gurnani, J. Dookhy, Y. Liu, Y. Li, S. O'Shea, S. Frank, R. Au, J. Mez, T. Alvin Ang, L. Shih (Framingham, USA)

    Objective: Characterize the cognitive profiles of individuals with PD within a population-based study Background: Understanding the cognitive state of those with PD early in its…
  • 2024 International Congress

    Critically Evaluating Best Practice Guidelines for Cognitive Impairment in Parkinson’s Disease: A Systematic Review (PDCogniCare)

    D. Pourzinal, D. Bailey, J. Yang, L. Mitchell, N. Pachana, D. Brooks, SA. Keramat, K. Shrubsole, J. Liddle, H. Tinson, S. Naismith, A. Lehn, R. Marsh, N. Dissanayaka (HERSTON, Australia)

    Objective: This systematic review aimed to critically evaluate current recommendations for evaluation, diagnosis and post-diagnostic care of cognitive impairment in Parkinson's disease (PD). Background: Methods…
  • 2024 International Congress

    α-Synuclein Pathology Across Movement Disorders and Neurodegenerative Diseases by Seed Amplification Assay

    S. Weber, C. Farris, Y. Ma, M. Dakna, M. Starke, C. Trenkwalder, L. Concha-Marambio, B. Mollenhauer (Goettingen, Germany)

    Objective: To assess the frequency of pathological α-synuclein (αSyn) in various movement disorders and neurodegenerative diseases from a specialized movement disorder clinic by αSyn seed…
  • 2024 International Congress

    Neuropsychological Tests of Language, Memory, and Visuospatial Function in Parkinson’s Disease: Review, Critique and Recommendations

    O. Bezdicek, R. Biundo, D. Cammisuli, B. Cholerton, J. Dalrymple-Alford, N. Edelstyn, E. Fiorenzato, E. Holker, S. Martinez-Horta, A. Martini, G. Santangelo, B. Segura, C. Siri, A. Troster, M. Skorvanek, D. Weintraub, G. Geurtsen (Praha, Czech Republic)

    Objective: To evaluate the psychometric properties of Language, Memory, and Visuospatial Function tests in Parkinson’s Disease (PD) on behalf of the Movement Disorder Society (MDS)…
  • 2024 International Congress

    Association Between DPP-4 Inhibitors Use and Risk of Dementia: A Meta-analysis Using Real-world Data

    S. Hussain (New Delhi, India)

    Objective: To investigate the potential association between the use of DPP-4 inhibitors and the risk of dementia, utilizing real-world data from diverse sources. Background: Evidence…
  • 2024 International Congress

    Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)

    D. Pourzinal, K. Sivakumaran, J. Yang, D. Bailey, L. Mitchell, D. Brooks, A. Lehn, J. Liddle, N. Pachana, H. Tinson, K. Shrubsole, N. Dissanayaka (Herston, Australia)

    Objective: This systematic review aimed to synthesise current neuropsychological predictors of cognitive decline in Parkinson's disease (PD). Background: The observed heterogeneity of cognitive function in…
  • 2024 International Congress

    Mixed Brain Pathology in Neurodegenerative Parkinsonism and Dementia

    K. Mensikova, L. Tuckova, D. Hrabos, A. Jawad, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To assess the presence of mixed neurodegenerative pathology and its proportion in the prospective cohort of patients treated for any phenotype of neurodegenerative parkinsonism,…
  • 2024 International Congress

    Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

    A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)

    Objective: To identify the impact of prodromal RBD in the incidence of cognitive impairment in patients with early PD. Background: The association between sleep disorders…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley